Perjeta, also known as pertuzumab, signifies a crucial advancement in managing HER2-positive mammary cancer. This drug works by inhibiting a specific pathway that helps cancer cells multiply . Unlike some other HER2-targeted therapies, pertuzumab doesn’t directly block the HER2 receptor itself, b… Read More